Skip to main content

Dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders

 

 

 

CEGIR Mission Statement

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.

Dr. Marc Rothenberg, MD, PhD poses with a CEGIR patient who wears a mask that reads, "Hero"

Join One of Our Research Studies

Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases

Find a Study

National Survey Reveals Impact of COVID-19 on People Living with Rare Diseases and Their Families

The devastating impact of COVID-19 on the general population is well-documented—but less is known about the millions of people living with rare diseases.

Flyer advertising the survey appearing on a laptop screen.

Join the RDCRN for Rare Disease Day at NIH on February 29, 2024

Don’t miss the in-person and virtual celebration of Rare Disease Day at NIH on Thursday, February 29, 2024, from 9 am to 5 pm EST.

Rare Disease Day at NIH. February 29, 2024. #RDDNIH.

Twenty Years of the Rare Diseases Clinical Research Network: Looking Back, Looking Ahead

The Rare Diseases Act of 2002 (H.R. 4013) enacted the establishment of the Rare Diseases Clinical Research Network (RDCRN) in 2003.

Keyword co-occurrence visualization map of RDCRN-supported publications 2004–2020.

Get to Know Us

Learn more about CEGIR, one of 20 consortia funded by the National Institutes of Health through the Rare Diseases Clinical Research Network. Together, we are working to better understand how Eosinophilic Gastrointestinal Diseases progress and to develop improved approaches for diagnosis and treatment.
Watch Now

CEGIR Updates

Newsletter of the Consortium of Eosinophilic Gastrointestinal Disease Researchers

An update from the Consortium of Eosinophilic Gastrointestinal Disease Researchers

Learn More
Newsletter Image